{"version":"1.0","provider_name":"Kardio.az","provider_url":"https:\/\/kardio.az\/en","title":"DOAK therapy in Patients with Kidney Disease - Kardio.az","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"F8lenM8wEA\"><a href=\"https:\/\/kardio.az\/en\/hekimler-ucun\/doak-therapy-in-patients-with-kidney-disease\/\">DOAK therapy  in Patients with Kidney Disease<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/kardio.az\/en\/hekimler-ucun\/doak-therapy-in-patients-with-kidney-disease\/embed\/#?secret=F8lenM8wEA\" width=\"600\" height=\"338\" title=\"&#8220;DOAK therapy  in Patients with Kidney Disease&#8221; &#8212; Kardio.az\" data-secret=\"F8lenM8wEA\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/kardio.az\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","thumbnail_url":"https:\/\/kardio.az\/wp-content\/uploads\/2024\/11\/depositphotos_185370416-stock-photo-render-human-kidney-medicines.jpg","thumbnail_width":1600,"thumbnail_height":1167,"description":"https:\/\/link.springer.com\/chapter\/10.1007\/978-3-030-74462-5_7 Atrial fibrillation and chronic kidney disease are on the rise worldwide and may coexist in the same patient. The rates of either thromboembolic or hemorrhagic events are increased in patients with kidney disease. Oral anticoagulation therapy, nowadays preferably with direct oral anticoagulants (DOACs), represents the cornerstone for ischemic stroke prevention in high-risk patients. However,..."}